Chronic total occlusion procedure registry
Part of Heart & circulation clinical trials.
This study collects data from patients who are having a procedure to open a completely blocked coronary artery. It may help improve future treatments for this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be scheduled for a procedure to open a completely blocked coronary artery (CTO PCI).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information from people who are having a procedure to open a completely blocked heart artery. It helps doctors learn more about these procedures and how to improve care for people like you.
This study looks at people with a long-standing complete blockage in a heart artery. The goal is to understand risk factors and outcomes, which may help guide future treatments.
This trial studies a special heart procedure (CTO-PCI) to open a blocked coronary artery in people with heart failure and ongoing symptoms. It may help improve blood flow to the heart and symptoms for carefully selected patients.
This study looks at the long-term (10-year) outcomes of a specific stenting technique for patients with a chronic total occlusion (a complete blockage that has been there for at least 3 months) in a major heart artery. It aims to see how well the procedure works over time.
This trial tests whether a special balloon coated with medicine (drug-coated balloon) can safely open a completely blocked heart artery, instead of using a permanent stent. It may be an option for people who have chronic chest pain or shortness of breath due to a long-standing blockage.
This trial tests two procedures—antegrade dissection/re-entry and the retrograde method—to treat a completely blocked artery. It compares which technique works better for patients with complex blockages.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.